Neuberger Berman Group LLC lowered its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI – Get Rating) by 39.8% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 230,120 shares of the medical instruments supplier’s stock after selling 152,194 shares during the quarter. Neuberger Berman Group LLC’s holdings in ICU Medical were worth $51,234,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Quadrant Capital Group LLC increased its position in shares of ICU Medical by 81.5% during the 1st quarter. Quadrant Capital Group LLC now owns 118 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 53 shares during the last quarter. Covestor Ltd increased its position in shares of ICU Medical by 86.4% during the 1st quarter. Covestor Ltd now owns 123 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 57 shares during the last quarter. Point72 Hong Kong Ltd purchased a new stake in shares of ICU Medical during the 1st quarter valued at about $94,000. Van ECK Associates Corp increased its holdings in ICU Medical by 16.1% in the 1st quarter. Van ECK Associates Corp now owns 469 shares of the medical instruments supplier’s stock worth $104,000 after acquiring an additional 65 shares in the last quarter. Finally, Group One Trading L.P. increased its holdings in ICU Medical by 54.6% in the 1st quarter. Group One Trading L.P. now owns 566 shares of the medical instruments supplier’s stock worth $126,000 after acquiring an additional 200 shares in the last quarter. Hedge funds and other institutional investors own 90.20% of the company’s stock.
ICU Medical Trading Down 3.8 %
Shares of ICUI opened at $161.72 on Monday. The company has a debt-to-equity ratio of 0.78, a current ratio of 2.45 and a quick ratio of 1.25. ICU Medical, Inc. has a 1 year low of $154.73 and a 1 year high of $251.77. The company has a 50 day simple moving average of $168.89 and a two-hundred day simple moving average of $188.79. The firm has a market cap of $3.86 billion, a P/E ratio of 385.06 and a beta of 0.57.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on ICUI shares. Raymond James reduced their target price on shares of ICU Medical from $208.00 to $190.00 and set an “outperform” rating for the company in a report on Tuesday, August 9th. KeyCorp reduced their target price on shares of ICU Medical from $230.00 to $225.00 in a report on Tuesday, August 9th. Finally, StockNews.com raised shares of ICU Medical from a “sell” rating to a “hold” rating in a report on Monday, September 5th.
About ICU Medical
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.
- Get a free copy of the StockNews.com research report on ICU Medical (ICUI)
- Kroger’s is Your One-Stop Consumer Staples Stock
- Adobe Perfects the Art of the Faceplant for Investors
- Tax Credits are the Incentives in the Inflation Reduction Act
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.